AU555093B2 - Calcium-antagonist composition - Google Patents

Calcium-antagonist composition

Info

Publication number
AU555093B2
AU555093B2 AU82384/82A AU8238482A AU555093B2 AU 555093 B2 AU555093 B2 AU 555093B2 AU 82384/82 A AU82384/82 A AU 82384/82A AU 8238482 A AU8238482 A AU 8238482A AU 555093 B2 AU555093 B2 AU 555093B2
Authority
AU
Australia
Prior art keywords
active compound
calcium
antagonistic
antagonist composition
sustaining dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU82384/82A
Other languages
English (en)
Other versions
AU8238482A (en
Inventor
Volker Buehler
Heinz Einig
Winfried Koch
Joachim Arthur Schwarz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6129505&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU555093(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by BASF SE filed Critical BASF SE
Publication of AU8238482A publication Critical patent/AU8238482A/en
Application granted granted Critical
Publication of AU555093B2 publication Critical patent/AU555093B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU82384/82A 1981-04-07 1982-04-06 Calcium-antagonist composition Ceased AU555093B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE31139019 1981-04-07
DE19813113901 DE3113901A1 (de) 1981-04-07 1981-04-07 Wirkstoffzubereitung zur oralen applikation

Publications (2)

Publication Number Publication Date
AU8238482A AU8238482A (en) 1982-10-14
AU555093B2 true AU555093B2 (en) 1986-09-11

Family

ID=6129505

Family Applications (1)

Application Number Title Priority Date Filing Date
AU82384/82A Ceased AU555093B2 (en) 1981-04-07 1982-04-06 Calcium-antagonist composition

Country Status (17)

Country Link
EP (1) EP0063266B1 (enrdf_load_stackoverflow)
JP (1) JPS57175113A (enrdf_load_stackoverflow)
AT (1) ATE14076T1 (enrdf_load_stackoverflow)
AU (1) AU555093B2 (enrdf_load_stackoverflow)
CA (1) CA1184497A (enrdf_load_stackoverflow)
DE (2) DE3113901A1 (enrdf_load_stackoverflow)
DK (1) DK157482A (enrdf_load_stackoverflow)
ES (1) ES8307496A1 (enrdf_load_stackoverflow)
FI (1) FI821253A7 (enrdf_load_stackoverflow)
GR (1) GR74770B (enrdf_load_stackoverflow)
HU (1) HU186855B (enrdf_load_stackoverflow)
IE (1) IE52985B1 (enrdf_load_stackoverflow)
IL (1) IL65328A (enrdf_load_stackoverflow)
NO (1) NO157204C (enrdf_load_stackoverflow)
NZ (1) NZ200244A (enrdf_load_stackoverflow)
PT (1) PT74705B (enrdf_load_stackoverflow)
ZA (1) ZA822327B (enrdf_load_stackoverflow)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4461759A (en) * 1983-01-03 1984-07-24 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of veropamil
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
LU86077A1 (fr) * 1985-09-18 1987-04-02 Pharlyse Sa Nouvelles formes galeniques du verapamil,leur fabrication et medicaments contenant ces nouvelles formes galeniques
LU86099A1 (fr) * 1985-09-30 1987-04-02 Pharlyse Formes galeniques a liberation prolongee du verapamil,leur fabrication et medicaments les contenant
IE58401B1 (en) * 1986-06-20 1993-09-08 Elan Corp Plc Controlled absorption pharmaceutical composition
US4981871A (en) * 1987-05-15 1991-01-01 Abelson Mark B Treatment of ocular hypertension with class I calcium channel blocking agents
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
US5230901A (en) * 1988-03-23 1993-07-27 Knoll Ag Sustained release tablet of a mixture of alginates and polyacrylates
DE3809764A1 (de) * 1988-03-23 1989-10-05 Knoll Ag Mischung aus alginaten und polyacrylaten und deren verwendung
ES2045281T3 (es) * 1988-07-13 1994-01-16 Knoll Ag Forma de medicamento de accion retardada sobre la base de alginatos.
US5032406A (en) * 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
DE3932378A1 (de) * 1989-09-28 1991-04-11 Knoll Ag Feste arzneiform mit hohem verapamil-gehalt
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
US6083532A (en) * 1995-03-01 2000-07-04 Duramed Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers and tablet formed therefrom
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1154810B (de) * 1961-04-01 1963-09-26 Knoll Ag Verfahren zur Herstellung basisch substituierter Phenylacetonitrile
DE1467781A1 (de) * 1963-07-15 1968-12-05 Boehringer Sohn Ingelheim Verfahren zur Herstellung von Dragees mit verlaengerter Wirkstofffreigabe

Also Published As

Publication number Publication date
HU186855B (en) 1985-10-28
NZ200244A (en) 1984-08-24
PT74705B (en) 1983-11-14
IL65328A (en) 1985-06-30
DE3113901A1 (de) 1982-10-28
IE52985B1 (en) 1988-04-27
DE3264519D1 (en) 1985-08-08
FI821253L (fi) 1982-10-08
JPS57175113A (en) 1982-10-28
ZA822327B (en) 1983-03-30
NO821084L (no) 1982-10-08
NO157204C (no) 1988-02-10
GR74770B (enrdf_load_stackoverflow) 1984-07-12
IE820812L (en) 1982-10-07
FI821253A7 (fi) 1982-10-08
FI821253A0 (fi) 1982-04-07
ATE14076T1 (de) 1985-07-15
ES511208A0 (es) 1983-08-16
EP0063266A3 (en) 1983-05-04
DK157482A (da) 1982-10-08
EP0063266A2 (de) 1982-10-27
EP0063266B1 (de) 1985-07-03
IL65328A0 (en) 1982-05-31
NO157204B (no) 1987-11-02
ES8307496A1 (es) 1983-08-16
AU8238482A (en) 1982-10-14
CA1184497A (en) 1985-03-26
PT74705A (en) 1982-05-01

Similar Documents

Publication Publication Date Title
AU555093B2 (en) Calcium-antagonist composition
EP0427247A3 (en) Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
DE60022895D1 (de) Pdgf-rezeptor-kinase hemmende verbindungen, deren herstellung, reinigung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
DE3566545D1 (en) 2-substituted-1,3-propylidenediphosphonate derivatives, the process for their preparation and pharmaceutical compositions containing them
DE3474774D1 (en) Therapeutic compositions for oral use containing stable s-adenosy1-l-methionine salts
DK0629400T3 (da) Idebenon-holdige præparater til behandling af Alzheimer's syge
CA2078869A1 (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
KR890004705A (ko) 항바이러스성 제제
ATE18203T1 (de) (-)-15-deoxyspergualin, seine herstellung und arzneimittel mit diesem wirkstoff.
ZA858742B (en) Anticoccidial compositions
ATE85218T1 (de) Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid.
HK8994A (en) Medicament for treatment of pregnancy-induced hypertension
WO1987003590A1 (en) Medicament for the treatment of diseases of the liver
IL87867A (en) Preparation of pharmaceutical compositions containing a 2,6-diamino-3-phenyl-azo-pyridine derivative
IE780530L (en) Anti-histamine salts and compositions
JPS54126737A (en) Antithrombotic agent
ATE15041T1 (de) Verbindung mit schmerzlinderungs-, entzuendungshemmungs- und antipyrexiewirkung, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
FR2567755B1 (fr) Nouveau medicament anti-tumoral contenant comme ingredient actif le triacetoxy-1,8,9 anthracene